$1.11
In chiusura: Oct 9 EDT
$1.08
-0.03-2.70%
Pre-mercato: 5:37 AM EDT
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Atossa Therapeutics Inc (NASDAQ:ATOS) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 3.57M a 2.80M. Questo rappresenta il 2.17% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Atossa Therapeutics Corp (XNAS:ATOS) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 516.82K azioni scambiate al giorno, ci vorrebbero 5.42 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
2.80M
Vendite allo scoperto %
2.17%
Giorni di copertura
5.42
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
ATOS | Atossa Therapeutics, Inc. Comm | 09/15/2025 | 09/24/2025 | 2.17% | 129,116,625 | 2,799,971 | 516,815 | 5.42 | |
ATOS | Atossa Therapeutics, Inc. Comm | 08/29/2025 | 09/10/2025 | 2.77% | 129,116,625 | 3,572,121 | 447,460 | 7.98 | |
ATOS | Atossa Therapeutics, Inc. Comm | 08/15/2025 | 08/26/2025 | 2.83% | 129,116,625 | 3,659,803 | 675,333 | 5.42 | |
ATOS | Atossa Therapeutics, Inc. Comm | 07/31/2025 | 08/11/2025 | 2.95% | 129,115,205 | 3,810,621 | 1,792,693 | 2.13 | |
ATOS | Atossa Therapeutics, Inc. Comm | 07/15/2025 | 07/24/2025 | 3.16% | 129,115,205 | 4,085,861 | 662,820 | 6.16 | |
ATOS | Atossa Therapeutics, Inc. Comm | 06/30/2025 | 07/10/2025 | 3.62% | 129,115,205 | 4,667,774 | 2,381,651 | 1.96 | |
ATOS | Atossa Therapeutics, Inc. Comm | 06/13/2025 | 06/25/2025 | 5.74% | 129,115,205 | 7,415,914 | 635,992 | 11.66 | |
ATOS | Atossa Therapeutics, Inc. Comm | 05/30/2025 | 06/10/2025 | 5.90% | 129,115,205 | 7,618,207 | 670,326 | 11.36 | |
ATOS | Atossa Therapeutics, Inc. Comm | 05/15/2025 | 05/27/2025 | 5.53% | 129,115,205 | 7,138,285 | 794,295 | 8.99 | |
ATOS | Atossa Therapeutics, Inc. Comm | 04/30/2025 | 05/09/2025 | 5.52% | 129,115,205 | 7,133,598 | 661,550 | 10.78 | |
ATOS | Atossa Therapeutics, Inc. Comm | 04/15/2025 | 04/25/2025 | 5.91% | 129,115,205 | 7,627,038 | 795,656 | 9.59 | |
ATOS | Atossa Therapeutics, Inc. Comm | 03/31/2025 | 04/09/2025 | 6.27% | 129,115,205 | 8,097,901 | 539,010 | 15.02 | |
ATOS | Atossa Therapeutics, Inc. Comm | 03/14/2025 | 03/25/2025 | 6.82% | 125,775,985 | 8,580,955 | 519,740 | 16.51 | |
ATOS | Atossa Therapeutics, Inc. Comm | 02/28/2025 | 03/11/2025 | 7.05% | 125,775,985 | 8,863,407 | 523,824 | 16.92 | |
ATOS | Atossa Therapeutics, Inc. Comm | 02/14/2025 | 02/26/2025 | 7.15% | 125,775,985 | 8,989,468 | 644,058 | 13.96 | |
ATOS | Atossa Therapeutics, Inc. Comm | 01/31/2025 | 02/11/2025 | 7.35% | 125,775,985 | 9,248,121 | 813,338 | 11.37 | |
ATOS | Atossa Therapeutics, Inc. Comm | 01/15/2025 | 01/27/2025 | 6.95% | 125,775,985 | 8,735,726 | 811,058 | 10.77 | |
ATOS | Atossa Therapeutics, Inc. Comm | 12/31/2024 | 01/10/2025 | 6.81% | 125,775,985 | 8,567,362 | 1,053,742 | 8.13 | |
ATOS | Atossa Therapeutics, Inc. Comm | 12/13/2024 | 12/24/2024 | 6.52% | 125,775,985 | 8,198,158 | 912,887 | 8.98 | |
ATOS | Atossa Therapeutics, Inc. Comm | 11/29/2024 | 12/10/2024 | 9.23% | 125,775,985 | 11,603,127 | 781,240 | 14.85 | |
ATOS | Atossa Therapeutics, Inc. Comm | 11/15/2024 | 11/26/2024 | 9.90% | 125,775,985 | 12,454,496 | 860,945 | 14.47 | |
ATOS | Atossa Therapeutics, Inc. Comm | 10/31/2024 | 11/11/2024 | 10.15% | 125,732,147 | 12,767,546 | 385,537 | 33.12 | |
ATOS | Atossa Therapeutics, Inc. Comm | 10/15/2024 | 10/24/2024 | 10.38% | 125,732,147 | 13,051,696 | 419,375 | 31.12 | |
ATOS | Atossa Therapeutics, Inc. Comm | 09/30/2024 | 10/09/2024 | 10.28% | 125,732,147 | 12,928,634 | 617,550 | 20.94 | |
ATOS | Atossa Therapeutics, Inc. Comm | 09/13/2024 | 09/24/2024 | 10.48% | 125,732,147 | 13,180,481 | 504,626 | 26.12 | |
ATOS | Atossa Therapeutics, Inc. Comm | 08/30/2024 | 09/11/2024 | 10.26% | 125,732,147 | 12,901,933 | 544,150 | 23.71 | |
ATOS | Atossa Therapeutics, Inc. Comm | 08/15/2024 | 08/26/2024 | 10.23% | 125,732,147 | 12,863,423 | 586,681 | 21.93 | |
ATOS | Atossa Therapeutics, Inc. Comm | 07/31/2024 | 08/09/2024 | 10.12% | 125,732,147 | 12,717,932 | 844,705 | 15.06 | |
ATOS | Atossa Therapeutics, Inc. Comm | 07/15/2024 | 07/24/2024 | 9.81% | 125,732,147 | 12,338,791 | 966,832 | 12.76 | |
ATOS | Atossa Therapeutics, Inc. Comm | 06/28/2024 | 07/10/2024 | 8.18% | 125,732,147 | 10,283,709 | 2,878,944 | 3.57 | |
ATOS | Atossa Therapeutics, Inc. Comm | 06/14/2024 | 06/26/2024 | 8.67% | 125,732,147 | 10,894,982 | 700,487 | 15.55 | |
ATOS | Atossa Therapeutics, Inc. Comm | 05/31/2024 | 06/11/2024 | 8.92% | 125,732,147 | 11,217,241 | 1,006,880 | 11.14 | |
ATOS | Atossa Therapeutics, Inc. Comm | 05/15/2024 | 05/24/2024 | 9.13% | 125,732,147 | 11,481,698 | 1,429,358 | 8.03 | |
ATOS | Atossa Therapeutics, Inc. Comm | 04/30/2024 | 05/09/2024 | 9.10% | 125,732,147 | 11,442,914 | 1,629,688 | 7.02 | |
ATOS | Atossa Therapeutics, Inc. Comm | 04/15/2024 | 04/24/2024 | 9.86% | 125,278,795 | 12,352,033 | 3,405,950 | 3.63 | |
ATOS | Atossa Therapeutics, Inc. Comm | 03/28/2024 | 04/09/2024 | 8.43% | 125,278,795 | 10,563,547 | 3,090,596 | 3.42 | |
ATOS | Atossa Therapeutics, Inc. Comm | 03/15/2024 | 03/26/2024 | 6.77% | 125,245,059 | 8,481,482 | 1,269,469 | 6.68 | |
ATOS | Atossa Therapeutics, Inc. Comm | 02/29/2024 | 03/11/2024 | 5.71% | 125,245,059 | 7,154,342 | 430,561 | 16.62 | |
ATOS | Atossa Therapeutics, Inc. Comm | 02/15/2024 | 02/27/2024 | 5.62% | 125,245,059 | 7,035,052 | 463,943 | 15.16 | |
ATOS | Atossa Therapeutics, Inc. Comm | 01/31/2024 | 02/09/2024 | 5.46% | 125,245,059 | 6,838,653 | 317,820 | 21.52 | |
ATOS | Atossa Therapeutics, Inc. Comm | 01/12/2024 | 01/24/2024 | 5.58% | 125,245,059 | 6,985,240 | 422,526 | 16.53 | |
ATOS | Atossa Therapeutics, Inc. Comm | 12/29/2023 | 01/10/2024 | 5.07% | 125,245,059 | 6,355,284 | 790,210 | 8.04 | |
ATOS | Atossa Therapeutics, Inc. Comm | 12/15/2023 | 12/27/2023 | 5.03% | 125,245,059 | 6,301,026 | 232,116 | 27.15 | |
ATOS | Atossa Therapeutics, Inc. Comm | 11/30/2023 | 12/11/2023 | 4.98% | 125,245,059 | 6,242,373 | 287,600 | 21.71 | |
ATOS | Atossa Therapeutics, Inc. Comm | 11/15/2023 | 11/27/2023 | 5.09% | 125,245,059 | 6,371,661 | 344,431 | 18.5 | |
ATOS | Atossa Therapeutics, Inc. Comm | 10/31/2023 | 11/09/2023 | 5.29% | 125,726,195 | 6,651,946 | 248,833 | 26.73 | |
ATOS | Atossa Therapeutics, Inc. Comm | 10/13/2023 | 10/24/2023 | 5.61% | 125,726,195 | 7,048,222 | 310,351 | 22.71 | |
ATOS | Atossa Therapeutics, Inc. Comm | 09/29/2023 | 10/10/2023 | 5.77% | 125,726,195 | 7,252,532 | 478,768 | 15.15 |
In cerca di azioni più vendute allo scoperto?